Trial Profile
Phase IV Study on QoL in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms Rev II
- 24 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2011 New trial record